Key facts
- This page summarizes Brent L. Saunders's Form 4 filing for ARS Pharmaceuticals, Inc. (SPRY).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 22 May 2025, 17:00.
Brent L. Saunders - 20 May 2025 Form 4 Insider Report for ARS Pharmaceuticals, Inc. (SPRY)
- Reporting relationship
- Director
- Issuer ticker
- SPRY
- Reported as of
- 20 May 2025
- Net transaction value
- -$1,588,824
- SEC form
- 4
- Accepted by SEC
- 22 May 2025, 17:00:11 UTC
- Prior SEC filing
- 28 Feb 2025
- Next SEC filing
- 27 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kathleen Scott, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Brent L. Saunders filed Form 4 for ARS Pharmaceuticals, Inc. (SPRY) on 22 May 2025.
Change
- Previous filing in this sequence was filed on 28 Feb 2025.
- Current net transaction value: -$1,588,824.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001268854
Primary reporting owner
SAUNDERS BRENT L
- Relationship
- Director
- Address
- C/O ARS PHARMACEUTICALS, INC., 11682 EL CAMINO REAL, SUITE 120, SAN DIEGO
- Signature
- /s/ Kathleen Scott, Attorney-in-Fact
- Signature date
- 22 May 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SPRY
transaction
Common Stock
Options Exercise
- Transaction value
- $121,200
- Shares
- +120,000
- Change %
- Price
- $1.01
- Shares after
- 120,000
- Date
- 20 May 2025
- Ownership
- Direct
SPRY
transaction
Common Stock
Sale
- Transaction value
- $1,710,024
- Shares
- -120,000
- Change %
- -100%
- Price
- $14.25
- Shares after
- 0
- Date
- 20 May 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SPRY
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -120,000
- Change %
- -20%
- Price
- $0.000000
- Shares after
- 470,950
- Date
- 20 May 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 120,000
- Exercise price
- $1.01
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The weighted average sale price for the transaction reported was $14.2502 and the range of prices were between $14.25 and $14.26. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Footnote F2
Immediately exercisable.